CoChat

A Joint Model for Multistate Disease Processes and Random Informative Observation Times, with Applications to Electronic Medical Records Data

Lange, Jane M., Hubbard, Rebecca A., Inoue, Lurdes Y. T., Minin, Vladimir N. · 2015 · Biometrics
Cited by 49

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Summary: Multistate models are used to characterize individuals’ natural histories through diseases with discrete states. Observational data resources based on electronic medical records pose new opportunities for studying such diseases. However, these data consist of observations of the process at discrete sampling times, which may either be pre-scheduled and non-informative, or symptom-driven and informative about an individual's underlying disease status. We have developed a novel joint observation and disease transition model for this setting. The disease process is modeled according to a latent continuous-time Markov chain; and the observation process, according to a Markov-modulated Poisson process with observation rates that depend on the individual's underlying disease status. The disease process is observed at a combination of informative and non-informative sampling times, with possible misclassification error. We demonstrate that the model is computationally tractable and devise an expectation-maximization algorithm for parameter estimation. Using simulated data, we show how estimates from our joint observation and disease transition model lead to less biased and more precise estimates of the disease rate parameters. We apply the model to a study of secondary breast cancer events, utilizing mammography and biopsy records from a sample of women with a history of primary breast cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/biom.12252

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 55

  1. Aalen, 1995, Phase type distributions in survival analysis, Scandinavian Journal of Statistics, 22, 447
  2. Andersen, 2002, Multi-state models for event history analysis, Statistical Methods in Medical Research, 11, 91, 10.1191/0962280202SM276ra · DOI · Paper page
  3. Andreetta, 2007, Adjuvant endocrine therapy for early breast cancer, Cancer Letters, 251, 17, 10.1016/j.canlet.2006.10.021 · DOI
  4. Baum, 1970, A maximization technique occurring in the statistical analysis of probabilistic functions of Markov chains, Annals of Mathematical Statistics, 41, 164, 10.1214/aoms/1177697196 · DOI · Paper page
  5. Boer, 2004, Diversity of model approaches for breast cancer screening: A review of model assumptions by the Cancer Intervention and Surveillance Network (CISNET) Breast Cancer Groups, Statistical Methods in Medical Research, 13, 525, 10.1191/0962280204sm381ra · doi:10.1191/0962280204sm381ra
  6. Buist, 2010, Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer, Breast Cancer Research and Treatment, 124, 863, 10.1007/s10549-010-1106-6 · DOI
  7. Buist, 2013, Long-term surveillance mammography and mortality in older women with a history of early stage invasive breast cancer, Breast Cancer Research and Treatment, 142, 153, 10.1007/s10549-013-2720-x · DOI
  8. Chapman, 1999, Competing risks analyses for recurrence from primary breast cancer, British Journal of Cancer, 79, 1508, 10.1038/sj.bjc.6690240 · doi:10.1038/sj.bjc.6690240
  9. Chen, 2010, Analysis of interval-censored disease progression data via multi-state models under a nonignorable inspection process, Statistics in Medicine, 29, 1175, 10.1002/sim.3804 · DOI
  10. Chen, 2011, Non-homogeneous Markov process models with informative observations with an application to Alzheimer's disease, Biometrical Journal, 53, 444, 10.1002/bimj.201000122 · DOI
  11. Chen, 2013, A correlated random effects model for non-homogeneous Markov processes with nonignorable missingness, Journal of Multivariate Analysis, 117, 1, 10.1016/j.jmva.2013.01.009 · DOI
  12. Chen, 2004, Semi-Markov models for multistate data analysis with periodic observations, Communications in Statistics—Theory and Methods, 33, 475, 10.1081/STA-120028679 · doi:10.1081/sta-120028679
  13. Cumani, 1982, On the canonical representation of homogeneous Markov processes modelling failure-time distributions, Microelectronics and Reliability, 22, 583, 10.1016/0026-2714(82)90033-6 · DOI · Paper page
  14. Daley, 2003, An Introduction to the Theory of Point Processes
  15. de Bock, 2006, Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: Long-term results of European Organisation for Research and Treatment of Cancer studies, European Journal of Cancer, 42, 351, 10.1016/j.ejca.2005.10.006 · DOI · Paper page
  16. Dean, 2009, Use of electronic medical records for health outcomes research: A literature review, Medical Care Research and Review, 66, 611, 10.1177/1077558709332440 · DOI · Paper page
  17. Demicheli, 1996, Time distribution of the recurrence risk for breast cancer patients undergoing masectomy: Further support about the concept of tumor dormancy, Breast Cancer Research and Treatment, 41, 177, 10.1007/BF01807163 · DOI · Paper page
  18. Dempster, 1977, Maximum likelihood from incomplete data via the EM algorithm, Journal of the Royal Statistical Society, 39, 1, 10.1111/j.2517-6161.1977.tb01600.x · DOI · Paper page
  19. Diggle, 2010, Geostatistical inference under preferential sampling, Journal of the Royal Statistical Society, Series C, 59, 191, 10.1111/j.1467-9876.2009.00701.x · DOI · Paper page
  20. Dillon, 2005, The accuracy of ultrasound, stereotactic, and clinical core biopsies in the diagnosis of breast cancer, with an analysis of false-negative cases, Annals of Surgery, 242, 701, 10.1097/01.sla.0000186186.05971.e0 · doi:10.1097/01.sla.0000186186.05971.e0
  21. Etzioni, 1997, Estimating asymptomatic duration in cancer: The AIDS connection, Statistics in Medicine, 16, 627, 10.1002/(SICI)1097-0258(19970330)16:6<627::AID-SIM438>3.0.CO;2-7 · doi:10.1002/(sici)1097-0258(19970330)16:6<627::aid-sim438>3.0.co;2-7
  22. Fassil, 2014, Approaches for classifying the indications for colonoscopy using detailed clinical data, BioMed Central Cancer, 14
  23. Fearnhead, 2006, An exact Gibbs sampler for the Markov-modulated Poisson process, Journal of the Royal Statistical Society, 68, 767, 10.1111/j.1467-9868.2006.00566.x · doi:10.1111/j.1467-9868.2006.00566.x
  24. Fenton, 2014, Distinguishing screening from diagnostic mammograms using medicare claims data, Medical Care, 52, 44, 10.1097/MLR.0b013e318269e0f5 · doi:10.1097/mlr.0b013e318269e0f5
  25. Freed, 1982, A Poisson process whose rate is a hidden Markov process, Advances in Applied Probability, 14, 21, 10.2307/1426731 · doi:10.2307/1426731
  26. Geiger, 2007, Recurrences and second primary breast cancers in older women with initial early-stage disease, Cancer, 109, 966, 10.1002/cncr.22472 · DOI · Paper page
  27. Gerhard, 2011, Apply the multivarate time-rescaling theorem to neural population models, Neural Computation, 23, 1452, 10.1162/NECO_a_00126 · DOI
  28. Gilbert, 2012, numDeriv: Accurate Numerical Derivatives
  29. Gruger, 1991, The validity of inferences based on incomplete observations in disease state models, Biometrics, 47, 595, 10.2307/2532149 · DOI
  30. Houssami, 2011, Accuracy and outcomes of screening mammography in women with a personal history of early-stage breast cancer, Journal of the American Medical Association, 305, 790, 10.1001/jama.2011.188 · doi:10.1001/jama.2011.188
  31. Hubbard, 2008, Modeling nonhomogeneous Markov processes via time transformation, Biometrics, 64, 843, 10.1111/j.1541-0420.2007.00932.x · doi:10.1111/j.1541-0420.2007.00932.x
  32. Kalbfleisch, 1985, The analysis of panel data under a Markov assumption, Journal of the American Statistical Association, 80, 863, 10.1080/01621459.1985.10478195 · DOI · Paper page
  33. Kang, 2007, Statistical methods for panel data from a semi-Markov process, with application to HPV, Biostatistics, 8, 252, 10.1093/biostatistics/kxl006 · DOI
  34. Kay, 1986, A Markov model for analysing cancer markers and disease states in survival studies, Biometrics, 42, 855, 10.2307/2530699 · DOI · Paper page
  35. Lange, 2013, Fitting and interpreting continuous-time latent Markov models for panel data, Statistics in Medicine, 32, 4581, 10.1002/sim.5861 · doi:10.1002/sim.5861
  36. Li, 2013, Semiparametric transformation models for panel count data with correlated observation and follow-up times, Statistics in Medicine, 32, 3039, 10.1002/sim.5724 · doi:10.1002/sim.5724
  37. Lindqvist, 2013, Proceedings of the 59th ISI World Statistics Congress, 25
  38. Longini, 1989, Statistical analysis of the stages of HIV infection using a Markov model, Statistics in Medicine, 8, 831, 10.1002/sim.4780080708 · DOI · Paper page
  39. Lu, 2012, Markov modulated Poisson process associated with state-dependent marks and its applications to the deep earthquakes, Annals of the Institute of Statistical Mathematics, 64, 87, 10.1007/s10463-010-0302-9 · doi:10.1007/s10463-010-0302-9
  40. Mark, 2013, An EM algorithm for continuous-time bivariate Markov chains, Computational Statistics & Data Analysis, 57, 504, 10.1016/j.csda.2012.07.017 · DOI
  41. Meira-Machodo, 2009, Multi-state models for the analysis of time-to-event data, Statistical Methods in Medical Research, 18, 195, 10.1177/0962280208092301 · DOI · Paper page
  42. Meyer, 1971, Démonstration simplifiée d'un théorème de Knight, Séminaire de probabilités de Strasbourg, 5, 191
  43. Moran, 2008, Long-term outcomes and clinicopathologic differences of African-American versus white patients treated with breast conservation therapy for early-stage breast cancer, Cancer, 113, 2565, 10.1002/cncr.23881 · doi:10.1002/cncr.23881
  44. R Core Team, 2013, R: A Language and Environment for Statistical Computing
  45. Robertson, 2011, Surveillance mammography for detecting ipsilateral breast tumour recurrence and metachronous contralateral breast cancer: A systematic review, European Radiology, 21, 2484, 10.1007/s00330-011-2226-z · doi:10.1007/s00330-011-2226-z
  46. Ryden, 1996, An EM algorithm for estimation in Markov-modulated Poisson processes, Computational Statistics & Data Analysis, 21, 431, 10.1016/0167-9473(95)00025-9 · DOI · Paper page
  47. Saint-Pierre, 2003, The analysis of asthma control under a Markov assumption with use of covariates, Statistics in Medicine, 22, 3755, 10.1002/sim.1680 · DOI
  48. Steele, 2010, Frontiers of Statistical Decision Making and Bayesian Analysis, 113
  49. Sun, 2005, Semiparametric regression analysis of longitudinal data with informative observation times, Journal of the American Statistical Association, 100, 882, 10.1198/016214505000000060 · DOI
  50. Sundberg, 1973, Maximum likelihood theory for incomplete data from an exponential family, Scandinavian Journal of Statistics, 1, 49
  51. Sweeting, 2010, Multi-state Markov models for disease progression in the presence of informative examination times: An application to hepatitis C, Statistics in Medicine, 29, 1161, 10.1002/sim.3812 · DOI
  52. Titman, 2011, Flexible nonhomogeneous Markov models for panel observed data, Biometrics, 67, 780, 10.1111/j.1541-0420.2010.01550.x · DOI
  53. Titman, 2008, A general goodness-of-fit test for Markov and hidden Markov models, Statistics in Medicine, 27, 2177, 10.1002/sim.3033 · DOI
  54. Titman, 2010, Semi-Markov models with phase-type sojourn distributions, Biometrics, 66, 742, 10.1111/j.1541-0420.2009.01339.x · DOI
  55. Wirtz, 2014, Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors, Breast Cancer Research and Treatment, 143, 541, 10.1007/s10549-013-2816-3 · DOI

Cited by

See all 49

Metadata

Authors
Lange, J. M., Hubbard, R. A., Inoue, L. Y. T., & Minin, V. N.
Venue
Biometrics
Published
2014-10-15
Volume
71
Issue
1
Pages
90-101
ISSN
  • 0006-341X
  • 1541-0420
Cited by
49
References
1
Language
en
Funders
NIH (R01-AI107034, R01-CA160239, U01-CA063731)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.